Wagener-Ryczek S, et al. Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors. BMC Cancer 2020 May 12;20(1):408. doi: 10.1186/s12885-020-06920-3
Mahjoubi L, Cecchi F, Massard C, Calabro F, Gazzah A, Bahleda R, et al. Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica. Tumori 2018 Dec;104(6):NP38-NP41. doi: 10.1177/0300891618763215